What is the management of steroid-induced (steroid) colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The management of steroid-induced colitis requires a stepwise approach, starting with corticosteroids, and potentially adding biologics such as infliximab or vedolizumab for refractory cases, as recommended by the most recent guidelines 1.

Initial Management

The initial management of steroid-induced colitis involves administering corticosteroids, with an initial dose of 1-2 mg/kg/day prednisone or equivalent, until symptoms improve to grade 1, and then starting a taper over 4-6 weeks 1.

  • Consider hospitalization for patients with dehydration or electrolyte imbalance.
  • Consider repeat colonoscopy in patients who are immunosuppression-refractory.
  • Should consider permanently discontinuing CTLA-4 agents.

Biologics for Refractory Cases

For patients with high-risk endoscopic features on initial endoscopy examination or inadequate response to steroids, consider early introduction of infliximab or vedolizumab in addition to steroids 1.

  • Infliximab is typically dosed at 5 mg/kg given intravenously, and vedolizumab is given intravenously at a 300-mg dose.
  • Both infusions are typically given at weeks 0,2, and 6, with a minority of patients receiving longer-term treatment.

Additional Considerations

Additional considerations for the management of steroid-induced colitis include:

  • Fecal microbiota transplant, JAK inhibitor tofacitinib, or IL-12–blocking antibody ustekinumab in patients who are refractory to previous immunosuppressants 1.
  • Endoscopic evaluation with EGD or colonoscopy is highly recommended for cases grade ≥ 2 to stratify patients for early treatment of biologics based on the endoscopic findings 1.
  • Resuming ICPi after symptoms improve to grade 1 may be considered when steroid taper is completed, risk and benefits reviewed if maintained on biologics, and/or if endoscopic and histologic remissions are achieved 1.

From the Research

Management of Steroid-Induced Colitis

There are no research papers to assist in answering this question as the provided studies focus on stercoral colitis, which is a different condition.

Management of Stercoral Colitis

  • The management of stercoral colitis depends on the severity of the illness, ranging from manual disimpaction and other conservative measures for most cases, to surgical intervention for complicated cases, such as stercoral perforation 2.
  • Urgent treatment with laxatives and fecal disimpaction is indicated to prevent perforation and peritonitis 3.
  • ED management includes fluid resuscitation, initiation of a multimodal bowel regimen, and if indicated, initiation of parenteral antibiotics and consultation with a surgical specialist 4.
  • Prompt resuscitation and surgical exploration with damage control surgery are recommended for stercoral colitis-induced ischemia 5.
  • Most patients with stercoral colitis require hospital admission, and the condition is associated with substantial short-term mortality 6.

Key Considerations

  • Stercoral colitis is a rare but serious diagnosis associated with a high rate of morbidity and mortality 4.
  • The condition often presents in a nonspecific manner, requiring a high index of suspicion for early diagnosis 3, 5.
  • CT scans are crucial for diagnosis, revealing key findings such as fecaloma, colonic dilatation, and fat stranding 2, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.